Our results indicate that amplification of BRD4 and RAC1 dependent signaling pathways servers as independent biomarkers for breast cancer prognosis and furthermore these findings highlights towards the importance of combined inhibition of RAC1 and BRD4 signaling in different molecular subtypes of breast cancer. Here, RAC1 is linked to breast cancer.